Skip to content

logo

SEARCH icon
  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage
Search

SEARCH FOR AN ARTICLE

  • Investing News
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Financial
  • Health
  • MORE
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Industrials
    • Food & Beverage

logo

icon

      HomeHealth

      Health

      Anteris’ DurAVR THV Demonstrates 1% Heart Failure Hospitalization, Single-Digit Gradients and No Valve-Related Deaths at 1 Year in Patients with Small Aortic Annuli
      Health

      Anteris’ DurAVR THV Demonstrates 1% Heart Failure Hospitalization, Single-Digit Gradients and No Valve-Related Deaths at 1 Year in Patients with Small Aortic Annuli

      November 22, 2026
      Surgery Partners, Inc. Announces Expiration and Results of Consent Solicitation Relating to Surgery Center Holdings, Inc.’s 7.250% Senior Notes due 2032
      Health

      Surgery Partners, Inc. Announces Expiration and Results of Consent Solicitation Relating to Surgery Center Holdings, Inc.’s 7.250% Senior Notes due 2032

      November 21, 2026
      MEDIROM Regains Compliance with Nasdaq’s Periodic Filing Requirement
      Health

      MEDIROM Regains Compliance with Nasdaq’s Periodic Filing Requirement

      November 21, 2026
      Novartis projects +5% cc¹ sales CAGR through 2031 and sustained mid-single-digit growth over the long term
      Health

      Novartis projects +5% cc¹ sales CAGR through 2031 and sustained mid-single-digit growth over the long term

      November 19, 2026
      Olema Oncology Presents Preclinical Data on Selective KAT6A Degraders in ER+/HER2- Breast Cancer Models at EORTC-NCI-AACR Symposium
      Health

      Olema Oncology Presents Preclinical Data on Selective KAT6A Degraders in ER+/HER2- Breast Cancer Models at EORTC-NCI-AACR Symposium

      November 18, 2026
      Nyxoah Obtains Default Decision Against Inspire Medical Systems in Unified Patent Court Case
      Health

      Nyxoah Obtains Default Decision Against Inspire Medical Systems in Unified Patent Court Case

      November 18, 2026
      Medline Inc. announces pricing of secondary offering of Class A common stock
      Health

      Medline Inc. announces pricing of secondary offering of Class A common stock

      November 18, 2026
      Novartis showcases hematology momentum and continued breast cancer leadership at ASH and SABCS
      Health

      Novartis showcases hematology momentum and continued breast cancer leadership at ASH and SABCS

      November 18, 2026
      Vivos Therapeutics Reports Third Quarter 2026 Financial Results and Provides Operational Update
      Health

      Vivos Therapeutics Reports Third Quarter 2026 Financial Results and Provides Operational Update

      November 17, 2026
      Novartis Cosentyx® becomes first and only FDA-approved anti-IL-17 biologic for people with polymyalgia rheumatica (PMR)
      Health

      Novartis Cosentyx® becomes first and only FDA-approved anti-IL-17 biologic for people with polymyalgia rheumatica (PMR)

      November 17, 2026
      1 2 3 … 226 »

       

      LATEST NEWS

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from Stock Street News.

      I want e-mail alerts, updates, and offers and agree to the StockStreetNews privacy policy.

      Market Jar Media Inc. © 2026